Loading companies…
Biotech
Physics-informed AI predicts molecular properties and chemical behavior for drug and materials research.
Azulene Labs applies physics-based AI to molecular simulation for drug discovery, materials development and industrial chemistry. Its models use quantum-mechanical training data to predict molecular properties and behavior, including protein-ligand binding and reaction energetics, helping research teams prioritize candidates computationally before costly experiments. The pre-seed financing will support team growth and product development.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $3.4M | Entrada Ventures — Participant |